Your browser is no longer supported. Please, upgrade your browser.
IQV [NYSE]
IQVIA Holdings Inc.
IndexS&P 500 P/E136.46 EPS (ttm)1.43 Insider Own0.40% Shs Outstand191.30M Perf Week3.00%
Market Cap37.03B Forward P/E21.11 EPS next Y9.22 Insider Trans-11.83% Shs Float189.20M Perf Month6.32%
Income279.00M PEG8.57 EPS next Q1.85 Inst Own93.10% Short Float1.22% Perf Quarter14.62%
Sales11.36B P/S3.26 EPS this Y-11.10% Inst Trans0.80% Short Ratio2.27 Perf Half Y24.55%
Book/sh30.56 P/B6.37 EPS next Y15.50% ROA0.60% Target Price219.35 Perf Year29.67%
Cash/sh8.11 P/C24.00 EPS next 5Y15.92% ROE2.30% 52W Range81.79 - 199.99 Perf YTD8.61%
Dividend- P/FCF37.82 EPS past 5Y-18.80% ROI3.60% 52W High-2.70% Beta1.38
Dividend %- Quick Ratio1.10 Sales past 5Y15.20% Gross Margin34.00% 52W Low137.91% ATR4.84
Employees67000 Current Ratio1.10 Sales Q/Q0.60% Oper. Margin5.20% RSI (14)63.87 Volatility2.19% 2.43%
OptionableYes Debt/Eq2.13 EPS Q/Q81.00% Profit Margin1.20% Rel Volume1.33 Prev Close191.05
ShortableYes LT Debt/Eq2.11 EarningsFeb 10 BMO Payout0.00% Avg Volume1.01M Price194.59
Recom1.80 SMA204.86% SMA506.49% SMA20019.48% Volume1,343,553 Change1.85%
Jul-07-20Initiated Stephens Equal-Weight $150
Mar-02-20Initiated Deutsche Bank Buy $190
Jan-08-20Initiated Wells Fargo Overweight $180
Jan-07-20Initiated Citigroup Buy $185
Dec-13-19Upgrade CFRA Sell → Hold
Nov-14-19Upgrade Wolfe Research Peer Perform → Outperform
Jun-21-19Upgrade Mizuho Neutral → Buy $150 → $175
May-28-19Initiated SVB Leerink Outperform
Jan-18-19Upgrade Jefferies Hold → Buy
Oct-09-18Initiated UBS Buy
Oct-02-18Reiterated Robert W. Baird Outperform $143 → $146
Jul-25-18Upgrade BofA/Merrill Neutral → Buy
Jul-25-18Reiterated Stifel Buy $128 → $150
Jul-03-18Upgrade Raymond James Outperform → Strong Buy
Apr-13-18Upgrade Goldman Neutral → Buy
Mar-07-18Upgrade SunTrust Hold → Buy
Jan-19-18Initiated Evercore ISI Outperform $112
Feb-17-21 04:27PM  
Feb-16-21 07:30AM  
03:41AM  
03:26AM  
12:35AM  
Feb-11-21 09:00AM  
08:00AM  
Feb-10-21 01:30PM  
10:27AM  
08:35AM  
07:23AM  
07:00AM  
Feb-09-21 09:29AM  
Feb-08-21 10:39AM  
Feb-05-21 05:04PM  
Feb-04-21 08:00AM  
Feb-03-21 12:31PM  
Feb-01-21 08:00AM  
Jan-26-21 04:15PM  
Jan-11-21 01:23AM  
Jan-05-21 08:00AM  
Dec-21-20 07:30AM  
Dec-17-20 08:00AM  
Dec-16-20 08:00AM  
Dec-09-20 10:10AM  
Dec-08-20 12:54PM  
Dec-07-20 08:00AM  
Dec-06-20 03:14AM  
Nov-19-20 11:30AM  
Nov-10-20 09:43AM  
Nov-05-20 09:35AM  
09:32AM  
Nov-02-20 08:00AM  
Oct-23-20 09:35AM  
Oct-20-20 03:00PM  
01:27PM  
10:58AM  
08:25AM  
07:16AM  
07:00AM  
Oct-19-20 10:14AM  
08:34AM  
Oct-15-20 10:00AM  
Oct-13-20 12:30PM  
08:58AM  
Oct-12-20 08:00AM  
Oct-07-20 04:15PM  
Oct-06-20 08:00AM  
Sep-23-20 09:46AM  
Sep-14-20 08:10AM  
Aug-31-20 01:45PM  
08:58AM  
Aug-26-20 02:59PM  
Aug-21-20 11:30AM  
10:54AM  
Aug-08-20 03:04PM  
Aug-05-20 08:00AM  
Aug-04-20 08:00AM  
Jul-31-20 11:09AM  
Jul-30-20 11:40AM  
Jul-29-20 08:00AM  
Jul-25-20 10:39AM  
Jul-23-20 08:00AM  
Jul-22-20 01:00PM  
10:18AM  
10:09AM  
08:25AM  
07:58AM  
07:30AM  
07:00AM  
Jul-21-20 06:12PM  
06:00PM  
06:00PM  
Jul-20-20 08:01AM  
Jul-17-20 11:27AM  
Jul-15-20 12:31PM  
Jul-14-20 11:07AM  
08:00AM  
Jul-08-20 04:15PM  
03:22PM  
Jul-02-20 08:00AM  
Jun-23-20 06:14PM  
Jun-09-20 09:24AM  
Jun-03-20 08:00AM  
Jun-02-20 10:58AM  
Jun-01-20 10:07AM  
May-28-20 01:18PM  
11:31AM  
May-27-20 07:14PM  
May-26-20 03:54PM  
May-21-20 08:00AM  
May-20-20 08:00AM  
May-11-20 10:08AM  
May-07-20 11:52AM  
May-01-20 08:36AM  
Apr-29-20 09:20AM  
Apr-28-20 06:01PM  
12:07PM  
11:01AM  
09:27AM  
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DANHAKL JOHN GDirectorDec 23Buy176.9563,45111,227,654137,410Dec 28 05:07 PM
Rittenmeyer Ronald ADirectorNov 24Sale172.969,5901,658,68611,894Nov 25 05:03 PM
Rittenmeyer Ronald ADirectorNov 16Sale174.3540,7927,112,08521,484Nov 18 05:03 PM
BOUSBIB ARISee RemarksOct 12Sale170.0069,12011,750,400652,035Oct 14 05:05 PM
BOUSBIB ARISee RemarksSep 15Sale164.3646,0807,573,709652,035Sep 17 05:06 PM
BOUSBIB ARISee RemarksAug 14Sale161.6669,12011,173,939652,035Aug 18 05:03 PM
STAUB W RICHARDSee RemarksAug 07Option Exercise87.2033,8902,955,12732,877Aug 11 05:02 PM
STAUB W RICHARDSee RemarksAug 07Sale160.3220,3673,265,33212,470Aug 11 05:02 PM
Bruehlman Ronald ESee RemarksAug 04Buy159.9410,0001,599,40026,751Aug 05 05:02 PM
TPG Group Holdings (SBS) AdvisFormer DirectorJul 28Sale159.122,919,051464,479,3950Jul 29 04:42 PM
BOUSBIB ARISee RemarksJul 22Sale160.0046,0807,372,800652,035Jul 24 05:09 PM
BOUSBIB ARISee RemarksJun 02Sale150.11164,87724,749,686652,035Jun 04 05:35 PM
BOUSBIB ARISee RemarksJun 01Sale150.0019,4432,916,450652,035Jun 03 05:35 PM
EVANISKO MICHAEL JDirectorMar 24Option Exercise21.206,600139,92011,850Mar 26 05:00 PM